Compare SSYS & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSYS | IRMD |
|---|---|---|
| Founded | 1989 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 654.9M | 1.3B |
| IPO Year | 2012 | 2014 |
| Metric | SSYS | IRMD |
|---|---|---|
| Price | $7.91 | $98.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 53.0K |
| Earning Date | 03-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $4.48 | $11.99 |
| Revenue Next Year | $3.23 | $9.91 |
| P/E Ratio | ★ N/A | $58.07 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $7.54 | $47.48 |
| 52 Week High | $12.78 | $107.90 |
| Indicator | SSYS | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.71 | 46.30 |
| Support Level | N/A | $97.37 |
| Resistance Level | $11.53 | $105.87 |
| Average True Range (ATR) | 0.32 | 2.76 |
| MACD | 0.03 | -0.14 |
| Stochastic Oscillator | 33.04 | 29.64 |
Stratasys Ltd offers polymer-based 3D printing solutions for designers, engineers, manufacturers, dental and medical professionals, and others. Its 3D printing systems utilize the firm's patented extrusion-based FDM, inkjet-based PolyJet, powder-bed-based SAF, photopolymer-based P3, and Neo stereolithography technologies to enable the production of prototypes, tools, and manufactured goods directly from 3D CAD files or other 3D content. The company's solutions portfolio comprises 3D printing systems, consumables, software, paid parts, and professional services, allowing end-users to effectively print 3D models, tools, and parts. Geographically, it generates maximum revenue from the United States, followed by Europe, Middle East and Africa, Asia-Pacific, and other regions.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.